• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体。疟疾研究的一种工具。

Monoclonal antibodies. A tool in malaria research.

作者信息

Epstein N

出版信息

Dev Biol Stand. 1984;57:129-32.

PMID:6084604
Abstract

The aim of this article is to review the role of monoclonal antibodies as a tool in malaria research. In particular we concentrate on a monoclonal antibody directed against a functional epitope on the merozoite surface. This antibody blocked the invasion of merozoites into the red blood cells by causing agglutination of the parasite. The antigenic determinant recognized by this mcAb, 13C11, is located on a major 230 K dalton glycoprotein of the mature Plasmodium knowlesi parasite. Using the 13C11 monoclonal antibody it was possible to follow the synthesis and insertion of this glycoprotein into the schizont membrane. The relation between the intraerythrocyte schizont and the extraerythrocyte merozoite components recognized by the 13C11 were defined. Furthermore, 13C11 was used to analyze the processing of the 230 Kd plasma-membrane component to lower molecular weight products which were present on the surface of the invasive merozoite and which might play a role in the invasion process.

摘要

本文旨在综述单克隆抗体作为疟疾研究工具的作用。特别地,我们聚焦于一种针对裂殖子表面功能性表位的单克隆抗体。该抗体通过引起寄生虫凝集,阻断了裂殖子侵入红细胞。这种单克隆抗体(13C11)识别的抗原决定簇位于成熟诺氏疟原虫主要的230千道尔顿糖蛋白上。利用13C11单克隆抗体,可以追踪这种糖蛋白在裂殖体膜中的合成与插入。确定了13C11识别的红细胞内裂殖体与红细胞外裂殖子成分之间的关系。此外,13C11被用于分析230千道尔顿质膜成分向低分子量产物的加工过程,这些低分子量产物存在于侵袭性裂殖子表面,可能在入侵过程中发挥作用。

相似文献

1
Monoclonal antibodies. A tool in malaria research.单克隆抗体。疟疾研究的一种工具。
Dev Biol Stand. 1984;57:129-32.
2
Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.用诺氏疟原虫140千道尔顿裂殖子表面蛋白对猴子进行免疫:该蛋白交替形式的出现。
J Immunol. 1985 Jun;134(6):4146-52.
3
Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes.针对诺氏疟原虫裂殖子上一种分子量为140,000的蛋白质的单克隆抗体可抑制其对恒河猴红细胞的侵袭。
J Immunol. 1984 Jan;132(1):438-42.
4
Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion.针对疟原虫(诺氏疟原虫)裂殖子上特定表面决定簇的单克隆抗体可阻断红细胞入侵。
J Immunol. 1981 Jul;127(1):212-7.
5
Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.伯氏疟原虫XAT:保护性155/160 kDa抗原位于裂殖体阶段寄生虫的寄生泡中。
Exp Parasitol. 2007 Aug;116(4):450-7. doi: 10.1016/j.exppara.2007.02.016. Epub 2007 Mar 7.
6
The malaria merozoite surface: a 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites.疟原虫裂殖子表面:一种分子量为140,000的蛋白质,在抗原性上与诺氏疟原虫裂殖子上的其他表面成分无关。
J Immunol. 1983 Jun;130(6):2886-90.
7
Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope.恶性疟原虫裂殖体和裂殖子195千道尔顿主要表面糖蛋白的单克隆抗体特性:鉴定额外的加工产物和血清型限制的重复表位
J Immunol. 1987 Feb 1;138(3):895-901.
8
Protective antigens of bloodstage Plasmodium knowlesi parasites.诺氏疟原虫血液期寄生虫的保护性抗原
Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):159-69. doi: 10.1098/rstb.1984.0116.
9
Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat.疟疾(诺氏疟原虫)裂殖子:免疫与表面被膜
J Immunol. 1975 Apr;114(4):1237-42.
10
Recognition of a Mr 56K glycoprotein on the surface of Plasmodium falciparum merozoites by mouse monoclonal antibodies.小鼠单克隆抗体对恶性疟原虫裂殖子表面56K先生糖蛋白的识别。
J Immunol. 1985 May;134(5):3439-44.

引用本文的文献

1
Monoclonal antibodies and immobilized antibodies. Patents and literature.单克隆抗体与固定化抗体。专利与文献。
Appl Biochem Biotechnol. 1987 Jun;15(1):53-80. doi: 10.1007/BF02798506.